PCSK9 Inhibitors: Indiana
March 1, 2018
A national data supplier reviewed PCSK9 inhibitor claims for managed care organizations in Indiana from January 2017 through December 2017.
Of health plans that received at least 150 claims for PCSK9 inhibitors, the following had the highest rates of rejections:
• Anthem – 58%
• Express Scripts – 42%
• MDwise – 37%
• CVS Health – 25%
The following had the lowest rates of rejection:
• Aetna – 10%
• Humana Health Plan – 9%
Tags: Cardiovascular, Prior Authorization
Categorized in: Report Cards